SEC Form D · filed March 8, 2022
CeleCor Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Neil Graham, Mbbs, M.D., Mph · Singapore, U0DirectorMichael S. Falk · West Palm Beach, FLDirectorMatthew Kennedy · New York, NYExecBenjamin Fogle · West Des Moines, IADirectorAndreas B. Ritzi · Zug, V8DirectorAlexandre M. Kaoukhov · Singapore, U0Exec · DirectorPaul J. Newfield · Wellington, Q2DirectorJack B. Lief · Del Mar, CADirectorSteven W. Davis · Birmingham, ALExecPeter B. Finn · Boston, MAExecRobert Hillman · Del Mar, CAExec · DirectorRobert A. O'Sullivan · West Palm Beach, FLExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗